The year in review: a look back on the top developments in real-world evidence in 2022

12 Jan 2023

Written by The Evidence Base

Artificial intelligence and machine learning Comparative effectiveness research Decision science Editorials Health economics Health policy Health technology assessment Industry Updates ISPOR Real-world evidence Regulation Stakeholder engagement

The past few years has seen the increasing utilization of real-world data/evidence (RWD/E) across the spectrum of drug development and healthcare decisions. The Evidence Base looks back on the most significant events from across the globe that took place in 2022 and are shaping the field of RWE for 2023 and beyond. In the UK It was a busy year for the National Institute for Health and Care Excellence (NICE) in the UK. At the start of 2022, NICE announced details of the changes to their methodology for health technology assessments (HTAs). The changes have been made to give patients...